Literature DB >> 8194468

Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells.

J M Quinn1, J O McGee, N A Athanasou.   

Abstract

Osteoclasts are multinucleated cells which form by fusion of circulating mononuclear hemopoietic precursors. The nature of these precursor cells and the roles bone stromal cells and hormonal factors play in their differentiation to osteoclasts are unknown. We cocultured adherent murine blood monocytes (nonspecific esterase and F4/80 positive; tartrate-resistant acid phosphatase negative) with osteoblastic and fibroblastic stromal cell lines in the presence of 2 x 10(-8) M 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. Tartrate-resistant acid phosphatase and calcitonin (CT) receptor-positive osteoclastic cells, which formed numerous resorption pits in vitro, were noted after only 4 days in coculture with UMR106 osteoblast-like cells. Resorption was seen in cocultures to which as few as 100 peripheral blood mononuclear cells had been added. 1,25-(OH)2D3 and contact with live bone stromal cells were absolute requirements for monocyte differentiation into bone-resorbing cells. Both salmon CT (5 IU/ml) and prostaglandin E2 (10(-6) M) significantly inhibited bone resorption. Thus, a significant proportion of the peripheral blood mononuclear cells in the monocyte fraction are capable of differentiating into cells showing the cytochemical and functional characteristics of osteoclasts. The presence of specific hormonal [1,25-(OH)2D3] and bone stromal cell elements is necessary for this process to occur; the resultant resorption can be modulated by known inhibitors of bone resorption, CT and prostaglandin E2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194468     DOI: 10.1210/endo.134.6.8194468

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.

Authors:  A Sabokbar; Y Fujikawa; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

2.  Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.

Authors:  R Pandey; J Quinn; C Joyner; D W Murray; J T Triffitt; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

3.  Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.

Authors:  I Itonaga; A Sabokbar; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

4.  Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells.

Authors:  A Sabokbar; Y Fujikawa; S Neale; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

5.  Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Authors:  Y Fujikawa; A Sabokbar; S Neale; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

6.  Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.

Authors:  R J van't Hof; A C Tuinenburg-Bol Raap; P J Nijweide
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

7.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Authors:  A Matayoshi; C Brown; J F DiPersio; J Haug; Y Abu-Amer; H Liapis; R Kuestner; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells.

Authors:  M J Steinbeck; J K Kim; M J Trudeau; P V Hauschka; M J Karnovsky
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

10.  Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications.

Authors:  Xuetao Shi; Yingjun Wang; Li Ren; Yihong Gong; Dong-An Wang
Journal:  Pharm Res       Date:  2008-11-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.